ILLUSIO is a plastic surgery simulation tool that enables a surgeon and patient to have a visual discussion about all of the possible outcomes of breast augmentation. Our revolutionary artistic platform gives the surgeon the perfect opportunity to create the ideal size and shape for every possible situation. The best part is that now the surgeon and patient will share the same visual expectation of surgery, and equally important, have a mutual understanding of the limitations of surgery based on the patients unique anatomy. Remember, ILLUSIO is primarily an artistic tool created to manage patient expectations. With ILLUSIO, the overall time per consult could become shorter and patients could make decisions quicker and with much more confidence. Above all, they will have fun with the process. The ability to look into our Virtual Mirror and see themselves with their virtual breasts is new and exciting and provides a real Wow experience. As patients become engaged in the process they will very likely want to share their ILLUSIO experience with their friends and family. Source
No articles found.
As a leading manufacturer of medical devices and components, Atrion makes a wide r...
As a leading manufacturer of medical devices an...
Spok, Inc., a wholly owned subsidiary of Spok Holdings, Inc. (NASDAQ: SPOK), headq...
Spok, Inc., a wholly owned subsidiary of Spok H...
Seattle-based Atossa Genetics (NASDAQ: ATOS) is a clinical-stage biopharmaceutical...
Seattle-based Atossa Genetics (NASDAQ: ATOS) is...
The next evolution in DNA-based diagnostics. MicroGen Vet is the exclusive reselle...
The next evolution in DNA-based diagnostics. Mi...
Avinger is a commercial-stage medical device company that designs, manufactures an...
Avinger is a commercial-stage medical device co...
Curis is a biotechnology company focused on the development and commercialization ...
Curis is a biotechnology company focused on the...
Balloonr is an SaaS platform deseigned to improve enterprise collaboration and dec...
Balloonr is an SaaS platform deseigned to impro...
Join the National Investor Network and get the latest information with your interests in mind.